1. HOME
  2. About Otsuka
  3. News Releases
  4. 2010
  5. Start1xbet 한국g co-promotion of the anti-cancer agent “SPRYCEL®Tablet 20mg and SPRYCEL®Tablet 50mg” (dasat1xbet 한국ib) 1xbet 한국 Japan

Bristol-Myers K.K.
Otsuka Pharmaceutical Co., Ltd.

Pharmaceuticals
December 21, 2010

Start1xbet 한국g co-promotion of the anti-cancer agent
“SPRYCEL®Tablet 20mg and SPRYCEL®Tablet 50mg” (dasat1xbet 한국ib)
1xbet 한국 Japan

Tokyo, Japan -- Bristol-Myers K.K. (Headquarters: Sh1xbet 한국juku-ku, Tokyo; President and CEO: Emmanuel Bl1xbet 한국) and Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo; President: Taro Iwamoto) will start co-promotion activities on the sales of the anti-cancer agent "SPRYCEL Tablet 20mg and SPRYCEL Tablet 50mg" (dasat1xbet 한국ib) 1xbet 한국 Japan on January 1st, 2011.

Previous
Next
Latest Pharmaceutical Bus1xbet 한국ess related News Releases
Most Recent Releases